We are pleased to offer a variety of senescent animal efficacy models to support senolytic drug discovery programs. We perform senescence-specific histology and biomarker (e.g. ELISA) endpoints. Advanced techniques include in vivo imaging and functional endpoints based on indication.
Representative study protocols for our most common study designs will be coming soon. For inquiries about our capabilities, please contact us.